Indian doctors have introduced new guidelines to address the growing obesity crisis, categorising it into two stages and ...

A study by Mass General Brigham investigators shows persistent racial disparities and growing sex disparities between ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

Anesthesiologist Joshua Hackett grew up in Chico, attended Chico State, and now practices in Humboldt County. He has a ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

A person with a BMI over 35 and those who would like to lose more than 20 pounds is the ideal non-diabetic candidates for GLP ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.